UBS Group Portfolio holdings
UBS Group AG, formed through the 1998 merger of Union Bank of Switzerland and Swiss Bank Corporation with roots dating back to 1862, is a Swiss multinational investment bank and financial services firm headquartered in Zurich. Renowned for its dominance in wealth management, UBS serves high-net-worth individuals and families globally, managing trillions in assets, while also offering investment banking, asset management, and retail banking services in Switzerland. The firm has weathered significant challenges, including a major bailout during the 2008 financial crisis, but has since refocused on stability and sustainable growth, emphasizing digital transformation and ESG (environmental, social, governance) investing. With a strong European base and a global reach, UBS remains a cornerstone of the international financial landscape.
Top Buys
| Rank | Stock | Value |
|---|---|---|
| 1 |
Strategy Inc
MSTR
|
+$1.21B |
| 2 |
State Street SPDR S&P 500 ETF Trust
SPY
|
+$855M |
| 3 |
Microsoft
MSFT
|
+$810M |
| 4 |
Advanced Micro Devices
AMD
|
+$805M |
| 5 |
Boeing
BA
|
+$739M |
Top Sells
| Rank | Stock | Value |
|---|---|---|
| 1 |
UnitedHealth
UNH
|
+$561M |
| 2 |
Amneal Pharmaceuticals
AMRX
|
+$169M |
| 3 |
Eli Lilly
LLY
|
+$161M |
| 4 |
Unity
U
|
+$158M |
| 5 |
State Street SPDR S&P Regional Banking ETF
KRE
|
+$127M |
Sector Composition
| Rank | Sector | Weight |
|---|---|---|
| 1 | Technology | 18.49% |
| 2 | Financials | 9.06% |
| 3 | Consumer Discretionary | 7.01% |
| 4 | Healthcare | 6.25% |
| 5 | Industrials | 6.22% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Change in Stake | Capital Flow | |
|---|---|---|---|---|---|---|
6276
MDB Capital Holdings
MDBH
$30.5M
| $262K | ﹤0.01% |
41,534
+9,763
| +31% | +$66.3K |
|
6277
Precision BioSciences
DTIL
$207M
| $261K | ﹤0.01% |
68,615
+66,732
| +3,544% | +$487K |
|
|
TSMZ
6278
Direxion Daily TSM Bear 1X ETF
TSMZ
$2.96M
| $261K | ﹤0.01% |
+12,098
| New | +$271K |
|
6279
iShares ESG MSCI USA Leaders ETF
SUSL
$1.2B
| $261K | ﹤0.01% |
2,534
+2,177
| +610% | +$227K |
|
|
ASPCU
6280
A SPAC III Acquisition Corp Unit
ASPCU
$62.5M
| $261K | ﹤0.01% |
+25,920
| New | +$260K |
|
6281
Hanover Bancorp
HNVR
$198M
| $260K | ﹤0.01% |
+11,287
| New | +$246K |
|
6282
Harbor Human Capital Factor US Large Cap ETF
HAPI
$506M
| $260K | ﹤0.01% |
+7,306
| New | +$262K |
|
6283
Skillful Craftsman
EDTK
$15.9M
| $260K | ﹤0.01% |
257,292
-9,559
| -4% | -$9.65K |
|
|
BWAY
6284
Brainsway
BWAY
$622M
| $259K | ﹤0.01% |
54,942
+51,624
| +1,556% | +$251K |
|
6285
Silvercrest Asset Management
SAMG
$79.9M
| $259K | ﹤0.01% |
14,085
+1,292
| +10% | +$22.9K |
|
|
AIRJ
6286
Montana Technologies Corp
AIRJ
$429M
| $257K | ﹤0.01% |
32,316
+32,308
| +403,850% | +$235K |
|
6287
Identive
INVE
$61.9M
| $257K | ﹤0.01% |
70,266
+50,266
| +251% | +$188K |
|
6288
DMC Global
BOOM
$157M
| $257K | ﹤0.01% |
34,925
+25,603
| +275% | +$242K |
|
6289
FibroBiologics
FBLG
$6.5M
| $256K | ﹤0.01% |
6,410
+4,242
| +196% | +$228K |
|
|
EBTC
6290
DELISTED
Enterprise Bancorp
EBTC
| $256K | ﹤0.01% |
6,471
+1,579
| +32% | +$56.8K |
|
6291
ATN International
ATNI
$492M
| $256K | ﹤0.01% |
15,210
+3,521
| +30% | +$82.3K |
|
6292
Cambria Global Momentum ETF
GMOM
$71.6M
| $254K | ﹤0.01% |
8,854
-481
| -5% | -$14.2K |
|
|
DRDBU
6293
Roman DBDR Acquisition Corp II Unit
DRDBU
| $254K | ﹤0.01% |
+25,500
| New | +$254K |
|
6294
Codexis
CDXS
$158M
| $254K | ﹤0.01% |
53,186
+14,844
| +39% | +$61.1K |
|
|
LNKB
6295
DELISTED
LINKBANCORP
LNKB
| $253K | ﹤0.01% |
33,869
+18,851
| +126% | +$134K |
|
6296
Alerus Financial
ALRS
$828M
| $252K | ﹤0.01% |
13,107
+3,460
| +36% | +$76K |
|
6297
Twin Disc
TWIN
$348M
| $252K | ﹤0.01% |
21,450
+12,373
| +136% | +$148K |
|
6298
Waldencast
WALD
$178M
| $251K | ﹤0.01% |
62,414
+50,888
| +442% | +$179K |
|
6299
Franklin FTSE South Korea ETF
FLKR
$1.39B
| $251K | ﹤0.01% |
14,403
+2,109
| +17% | +$41K |
|
6300
Colterpoint Net Lease Real Estate ETF
NETL
$54.3M
| $250K | ﹤0.01% |
10,646
+1,604
| +18% | +$40.9K |
|
Similar funds
UBS Group's Q4 2024 Portfolio in Review
As of Q4 2024, UBS Group held 10,816 positions worth $541B, up 18% from $459B the previous quarter. Its ten largest holdings account for 16% of the portfolio.
UBS Group deployed $80.6B of net new capital in Q4 2024, opening 1,382 new positions and adding to 6,044 existing holdings. Its largest new stake was Primo Brands: 1,234,826 shares worth $38M.
By sector, the portfolio is most concentrated in Technology at 18% of assets, up from 17% a quarter earlier, followed by Financials and Consumer Discretionary.
On the sell side, the largest reduction was UnitedHealth, an estimated $561M trimmed.
- UBS Group's largest Q4 2024 buy was Primo Brands: 1,234,826 shares worth $38M.
- UBS Group added most to Strategy Inc in Q4 2024, an estimated $1.21B increase.
- UBS Group's biggest Q4 2024 reduction was UnitedHealth, cutting an estimated $561M.
- UBS Group fully exited CATALENT, INC. in Q4 2024, selling an estimated $86M.
- UBS Group's ten largest holdings make up 16% of its $541B portfolio in Q4 2024.
- UBS Group opened 1,382 new positions and closed 943 in Q4 2024.
- UBS Group's portfolio value rose 18% quarter-over-quarter to $541B.
Based on UBS Group's 13F filing for Q4 2024, filed 14 Feb 2025.